Resources

Report: How employers view the weight-loss medication tsunami

GLP-1s have reshaped obesity treatment and healthcare in 2023. What's next in 2024? Accolade's report unpacks trends, costs, and HR insights to help guide employers toward understanding their role in the care continuum of treating obesity

In this resource

In 2023, GLP-1 medications have stormed the healthcare scene as a treatment for obesity. But what does 2024 hold? Our report dives into the shifting attitudes of benefits planners towards these treatments. Discover key insights from HR decision-makers, explore cost implications, and understand the rising demand for trusted information.

Are you prepared to optimize your benefits package for an increasingly health-conscious world? Get ahead with Accolade’s comprehensive employee health trends report.

Resources you might like

The future of personalized healthcare starts today.

Simplify benefits and drive a more integrated experience for our members

Aon validates Accolade healthcare claims cost reduction

Report: How employers view the weight-loss medication tsunami

In this resource

Resources you might like

A second opinion uncovers a life-altering autism diagnosis

Five key advantages to offering employees a second opinion benefit

Your blueprint for selling digital health and MSK solutions to your CFO

Ready for Personalized Healthcare?